Danni Wu
6 Papers
1 Citations
Danni Wu is an academic researcher. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
Andrea B. Troxel,Eva Petkova,Keith Goldfeld,Mengling Liu,Thaddeus Tarpey,Yinxiang Wu,Danni Wu,Anup Agarwal,Cristina Avendaño-Solá,E. Bainbridge,Katherine J Bar,Timothy Devos,Rafael F. Duarte,Arvind Gharbharan,Priscilla Y. Hsue,Gunjan Kumar,Anne F Luetkemeyer,Geert Meyfroidt,André Moraes Nicola,Aparna Mukherjee,Mila Brum Ortigoza,Liise Anne Pirofski,Bart J. A. Rijnders,Casper Rokx,Arantxa Sancho-Lopez,Pamela A. Shaw,Pablo Tebas,Hyun Ah Yoon,Corita R. Grudzen,Judith S. Hochman,Elliott M. Antman +30 more
TL;DR: It is suggested that real-time individual patient data pooling and meta-analysis during a pandemic are feasible, offering a model for future research and providing a rich data resource.
Bayesian Index Models for Heterogeneous Treatment Effects on a Binary Outcome
TL;DR: In this paper , a Bayesian model with a flexible link function connecting a binary treatment response to a linear combination of covariates and a treatment indicator and the interaction between the two is developed.
Bayesian index models for heterogeneous treatment effects
Hyung Cheol Park,Danni Wu,Eva Petkova,Thaddeus Tarpey,R. Todd Ogden +4 more
- 03 May 2022
TL;DR: In this article , the authors developed a Bayesian model with a link function connecting an exponential family treatment response to a linear combination of covariates and a treatment indicator and the interaction between the two.
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
Hyung Cheol Park,Thaddeus Tarpey,Mengling Liu,Keith Goldfeld,Yinxiang Wu,Danni Wu,Yi Hwei Li,Jinchun Zhang,Dipyaman Ganguly,Yogiraj Ray,S. R. Paul,Prasun Bhattacharya,Artur Belov,Yingzi Huang,C. Villa,Richard A. Forshee,Nicole C. Verdun,Hyun Ah Yoon,Anup Agarwal,Ventura A Simonovich,Paula Scibona,Leandro Burgos Pratx,Waldo H. Belloso,Cristina Avendaño-Solá,Katharine J. Bar,Rafael F. Duarte,Priscilla Y. Hsue,Anne F Luetkemeyer,Geert Meyfroidt,André Moraes Nicola,Aparna Mukherjee,Mila Brum Ortigoza,Liise Anne Pirofski,Bart J. A. Rijnders,Andrea B. Troxel,Elliott M. Antman,Eva Petkova +36 more
TL;DR: This prognostic study of 2287 patients hospitalized with COVID-19 identified a combination of baseline characteristics that predict a gradation of benefit from CCP compared with treatment without CCP.